Parkside Financial Bank & Trust’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Parkside Financial Bank & Trust’s Portfolio LFSC Stock Details LFSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,215	Closed	-$27.3K	–	3028
2025 Q1	$27.3K	Buy	+1,215	New	+$29.6K	﹤0.01%	1037

Other funds holding LFSC

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parkside Financial Bank & Trust's LFSC Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of F/m Emerald Life Sciences Innovation ETF (LFSC) in Q2 2025, closing a stake of 1,215 shares — an estimated $27.3K sold.

Parkside Financial Bank & Trust first reported a position in LFSC in Q1 2025 and held it in 1 quarter. The position peaked at $27.3K in Q1 2025. 3 funds tracked by Wall St. Rank hold LFSC as of Q2 2025.

Parkside Financial Bank & Trust reported no remaining F/m Emerald Life Sciences Innovation ETF position as of Q2 2025 after selling out during the quarter.
Parkside Financial Bank & Trust sold 1,215 F/m Emerald Life Sciences Innovation ETF shares in Q2 2025, an estimated $27.3K.
Parkside Financial Bank & Trust first reported a position in F/m Emerald Life Sciences Innovation ETF in Q1 2025 and held it in 1 quarter.
Parkside Financial Bank & Trust's F/m Emerald Life Sciences Innovation ETF position peaked at $27.3K in Q1 2025.
3 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.